Search

  • Sort by

  • Category

  • Post Type

  • Reset

McElhaney-NADDI-HB19

March 13, 2019
Posted in ,

Statement of Lisa McElhaney, President, National Association of Drug Diversion Investigators to Members of the Health & Human Services Committee Florida House of Representatives, March 11, 2019

Read More

ASOP Concerns with Wholesale Importation. Final Letter – FL

March 13, 2019
Posted in ,

Alliance for Safe Online Pharmacies, Letter to Members of the Health & Human Services Committee Florida House of Representatives, March 11, 2019

Read More
Gregg Keller, source: Gage Skidmore, via Wikimedia Commons

Former Executive Director of the American Conservative Union believes importation will hurt Americans

March 12, 2019
Posted in ,

In this editorial, published in The Missouri Times on March 11, 2019, Gregg Keller warns that “the issue at hand is not so much the safety of Canadian drugs but the dangers of the global drug trade. Often, pharmacies that claim to be “Canadian” are anything but.”

Read More

Gregg Keller

March 12, 2019
Posted in

Gregg Keller, source: Gage Skidmore, via Wikimedia Commons

Read More

Statements Opposing Drug Importation Reference

March 12, 2019

Download this 1-page reference list of letters opposing importation.

Read More

Statements Opposing Drug Importation – Summary List

March 12, 2019

2022 update

Read More

Guilty Plea From Canadian Who Sold Fentanyl-Laced Candies Via The Internet

March 12, 2019
Posted in ,

The U.S. Department of Justice announced that Christopher Bantli of Calgary, Canada pleaded guilty in federal court. Bantli distributed controlled substances to customers who made their purchases online. The substances, such as fentanyl, alprazolam, or U-47700, could be pressed to look like “Pez” candies…

Read More

Bantli_Statement_of_Facts

March 12, 2019
Posted in
Read More

Bantli_Indictment

March 12, 2019
Posted in
Read More

Nayyar GM., Breman JG, Et Al. Falsified and Substandard Drugs: Stopping the Pandemic AJTMhH 2019 Mar; 18-0981.

March 11, 2019
Posted in , ,

Abstract Falsified and substandard medicines are associated with tens of thousands of deaths, mainly in young children in poor countries. Poor-quality drugs exact an annual economic toll of up to US$200 billion and contribute to the increasing peril of antimicrobial resistance. The WHO has emerged recently as the global leader in the battle against poor-quality drugs, and pharmaceutical companies have…

Read More